DISCOVERY AND ENTREPRENEURSHIP SERIES - 6
Yi Liu, Ph.D.
Chief Scientific Officer of Wellspring Biosciences Inc.
Topic
Innovation First ─ my experience in transitioning from a scientist to an entrepreneur
Speaker
Yi Liu, Ph.D., is Chief Scientific Officer of Wellspring Biosciences Inc., a private biopharmaceutical company he co-founded in July 2012.
From October 2014 to November 2018, Dr. Liu served as Chief Scientific of Kura Oncology, a public company he co-founded in October 2014. Dr. Liu also co-founded Intellikine, Inc., a private biopharmaceutical company, where he served as Vice President of Drug Discovery from 2007 to May 2012, until its acquisition by Takeda Pharmaceuticals. Prior to Intellikine, Dr. Liu was the head of the drug design group at the Genomics Institute of the Novartis Research Foundation. Earlier in his career, he held senior scientist positions at both SGX Pharmaceuticals, Inc., a public biopharmaceutical company which was acquired by Eli Lilly and Company in 2008, and Curagen Corporation, a public biopharmaceutical development company.Dr. Liu received his Ph.D. in Biochemistry from Princeton University, his MSc in computational chemistry from Beijing University and his BE in Chemical Engineering from Tsinghua University.
When
February 16 (Sat), 2019
6:30 – 7:00 pm Networking
7:00 – 8:30 pm Seminar
Where
Irvine Ranch Water District, 15500 Sand Canyon Ave., Irvine, CA 92618
Free Registration
Registration is free but required (max 70 registrants). Parking is free. Light food/snacks are provided.
WebEx link will be provided to registrants upon request only.
Questions
Email: Sabpa.ocla@gmail.com
